Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 10/20 | 0.55 |
| ▸ | RARA | P10276 | 2/20 | 0.55 |
| ▸ | RARG | P13631 | 1/20 | 0.55 |
| ▸ | THRA | P10827 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.41 |
| ▸ | TACR2 | P21452 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17759278 | 0.89 | RARB (0.62) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL6517523 | 0.85 | RARB (0.58) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL16258070 | 0.82 | RARB (0.61) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL6558048 | 0.82 | RARB (0.61) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL16258126 | 0.82 | RARB (0.61) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL10381105 | 0.82 | RARB (0.58) | RARBRARATHRATHRBHSD17B10 | |
| SCHEMBL8613679 | 0.81 | RARB (0.54) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL9763676 | 0.81 | RARB (0.64) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL9763794 | 0.81 | RARB (0.64) | RARBRARARARGHSD17B10TSHR | |
| SCHEMBL9763579 | 0.81 | RARB (0.64) | RARBRARARARGHSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1179522-B1 | Liquid crystalline compound having a difluoropropyleneoxy group as bonding group, liquid crystal composition and liquid crystal display element | CHISSO CORP (JP) | 2005-12-07 | — | — | EP | disclosed |
| US-6544604-B2 | Large dielectric anisotropy and low refractive anisotropy; for driving elements at low voltage | CHISSO CORPORATION (JP) | 2003-04-08 | — | — | US | disclosed |
| US-20020119260-A1 | Liquid crystalline compound having difluoropropyleneoxy group as bonding group, liquid crystal composition and liquid crystal display element | JNC PETROCHEMICAL CORPORATION (JP) | 2002-08-29 | — | — | US | disclosed |
| EP-1179522-A1 | Liquid crystalline compound having a difluoropropyleneoxy group as bonding group, liquid crystal composition and liquid crystal display element | CHISSO CORPORATION (JP) | 2002-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119260-A1 | Liquid crystalline compound having difluoropropyleneoxy group as bonding group, liquid crystal composition and liquid crystal display element | OCIAD2, HCN2, OCIAD1 | RARB 3521/4885RARA 3567/4885RARG 3770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.